Abstract
During the past decade it has been suggested that aluminum may be substantially more toxic to the human body than had previously been thought (1). Much evidence has accumulated implicating aluminum, either directly or indirectly, in the pathogenesis of several forms of progressive central nervous system dysfunction, bone disease, and possibly cardiac and hematologic disturbances. For reasons which will be discussed below patients with renal insufficiency may be at greater risk of developing these sequelae which appear to be associated with an increasingly positive body aluminum balance. Although these problems have been reported almost exclusively in adults, it has become increasingly apparent that pediatric patients may be similarly affected. Consequently, an understanding of the current status of aluminum as a potential toxin is important to those caring for children with chronic renal disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Campbell, I.R., Cass, J.S., Cholak, J. et al: Aluminum in the environment of man. AMA Arch. Indust. Health 15: 359, 1957.
Trace Elements in Human and Animal Nutrition (4th Ed.), Underwood, E. (ed.), Academic Press, N.Y., 1977, p. 431.
McDermott, J.R., Smith, A.I., Igbal, K. et al.: Brain aluminum in aging and Altzheimer disease. Neurol. 29: 809, 1979.
Kaehny, W.D., Hegg, A.P. and Alfrey, A.C.: Gastrointestinal absorption of aluminum from aluminum-containing antacids. N. Engl. J. Med. 296 (24): 1389, 1977.
Rozas, V.V., Port, F.K. and Easterling, R.E.: An outbreak of dialysis dementia due to aluminum in the dialysate. J. Dial. 2 (5 & 6): 459, 1978.
Dunea, G., Mahurkar, S.D., Mamdani, B. et al.: Role of aluminum in dialysis dementia. Ann. Intern. Med. 88: 502, 1978.
Gorsky, J.E., Dietz, A.A., Spencer, H. et al.: Metabolic balance of aluminum studied in six men. Clin. Chem. 25 (10): 1739, 1979.
Arieff, A.I., Cooper, J.D. Armstrong, D. et al.: Dementia, renal failure and brain aluminum. Ann. Intern. Med. 90: 741, 1979.
Mayor, G.H., Keiser, J.A., Makdani, D. et al.: Aluminum absorption and distribution: Effect of parathyroid hormone. Science 197: 1187, 1977.
Clarkson, E.M., Luck, U.A., Hynson, W.V. et al.: The effect of aluminum hydroxide on calcium phosphorus and aluminum balances, the serum parathyroid hormone concentration and the aluminum content of bone in patients with chronic renal failure. Clin. Sci. 43: 519, 1972.
Boukari, M., Rottembourg,L., Jaudon, M-C. et aL: Influence de la prise prolongee de gels d’aluminum sur les taux seriques d’aluminum chez les patients atteintes d’insuffisance renale chronique. Nouv. Presse Med. 7 (2): 85, 1978,
Recker, R.R., Blotcky, A.J., Leffler, J.A. et al.: Evidence for aluminum absorption from the gastrointestinal tract and bone deposition by aluminum carbonate ingestion with normal renal function. J. Lab. Clin. Med. 90 (5): 810, 1978.
Hendricks, D., Mayor, G.H. and Sanchez, T.V.: Antemortem assessment of aluminum burdens in dialysis patients. (Abst.) Kidney Int. 12: 456, 1977.
Gorsky, J.E. and Dietz, A.A. : Determination of aluminum in biologic samples by atomic absorption spectrophotometry with a graphite furnace. Clin. Chem. 24: 1485, 1978.
Clavel, J.P., Jaudon, M.D. and Galli, A.: Dosage de 1’aluminum dans les liquides biologiques par spectrophotometric d’absorption atomique en four graphite. Ann. Biol. Clin. 36: 33, 1978.
Zumkley, H., Bertram, H.P., Lison, A. et aL: Aluminum, zinc and copper concentrations in plasma in chronic renal insufficiency. Clin. Nephrol. 12 (1): 18, 1979.
Salvedo, A., Minia, C., Segagni, S. et aL: Trace metal changes in dialysis fluid and blood of patients on hemodialysis. Int. J. Artif. Organs 2: 17, 1979.
Versieck, J.: Measuring aluminum levels (letter). N. Engl. J. Med. 302: 468, 1980.
Mayor, G.H., Sprague, S.M., Hourani, M.R. et aL: Parathyroid hormone-mediated aluminum deposition and egress in the rat. Kidney Int. 17: 40, 1980.
McDermott, J.R., Smith, A.I., Ward, M.K. et al.: Brainaluminum concentration in dialysis encephalopathy. Lancet 1: 901, 1978.
Kaehny, W.D., Alfrey, A.C., Holman, R.E. et al.: Aluminum transfer during hemodialysis. Kidney Int. 12: 361, 1977.
King, S.W., Willis, M.R. and Savory, J.: Serum binding of aluminum. Res. Clin. Pathol. & Pharmacol. 26 (6): 161, 1979.
Elliott, H.L., Macdougall, A.I., Fell, G.S. et aL: Plasmapheresis, aluminum, and dialysis dementia. Lancet 2: 1255, 1978.
Alfrey, A.C., LeGendre, G.R. and Kaehny, W.D.: The dialysis encephalopathy syndrome. N. Engl. J. Med. 294 (4): 184, 1976.
Elliott, H.L., Dryburgh, F., Fell, G.S. et al: Aluminum toxicity during regular hemodialysis. Br. Med. J. 1: 1101, 1978.
Kovalchik, M.T., Kaehny, W.D., Hegg, A.P. et al: Aluminum kinetics during hemodialysis. J. Lab. Clin. Med. 92 (5): 712, 1979.
Shaver, C.G. and Riddell, A.R.: Lung changes associated with the manufacture of aluminum abrasives. J. Indust. Hyg. Toxic 29 (3): 145, 1947.
Hypophosphatemia — Medical Staff Conference, University of California, San Francisco, West J. Med. 122: 482, 1975.
DeBoni, U., Scott, J.W. and Crapper, D.R.: Intracellular aluminum binding: a histochemical study. Histochemie 40: 31, 1974.
Miller, C.A. and Levine, E.M.: Effects of aluminum salts on cultured neuroblastoma cells. J. Neurochem. 22: 751, 1974.
Harrison, W.H., Codd, E. and Gray, R.M.: Aluminum inhibition of hexokinase. Lancet 2: 277, 1972.
Leeming, R.J. and Blair, J.A.: Dialysis dementia, aluminum and tetrahydrobiopterin metabolism. Lancet 1: 556, 1979.
Huber, C.T. and Frieden, E.: The inhibition of ferroxidase by trivalent and other metal ions. J. Biol. Chem. 245 (15): 3979, 1970.
Bone, I. and Thomas, M.: Dialysis dementia, aluminum and tetrahydrobiopterin metabolism. Lancet 1: 782, 1979.
Colburn, R.W. and Maas, J.W.: Adenosine triphosphate-metalnorepinephrine ternary complexes and catecholamine binding. Nature 208 (5005): 37, 1965.
Kirshner, N.: Uptake of catecholamines by a particulate fraction of the adrenal medulla. J. Biol. Chem. 237 (7): 2311, 1962.
Bonhaus, D.W., McCormack, K.M., Major, G.H. et al.: Effect of aluminum on microtubule subunit protein aggregation in vitro and microtubule formation in vivo. (Abst.) Kidney Int. 14: 671, 1978.
Crapper, D.R., Krishnan, S.S. and Dalton, A.J.: Brain aluminum distribution in Alzheimer disease and experimental neurofibrillary degeneration. Science 180: 511, 1973.
Crapper, D.R., Krishnan, S.S. and Quittkat, S.: Aluminum, neurofibrillary degeneration and Alzheimer disease. Brain 99: 67, 1976.
Doellken, V.: Uber die Wirkung des aluminium mit besonderer berucksichtigung der durch das aluminum versursachten lasionen in Zentralnervensystem. Naunyn-Schmiedebergs Arch. Exp. Path. Pharmak. 40: 58, 1897.
Kopeloff, L.M., Barrera, S.E. and Kopeloff, N.: Recurrent convulsive seizures in animals produced by immunologic and chemical means. Am. J. Psychiat. 98: 881, 1942.
Klatzo, I., Wisniewski, H. and Streicher, E.: Experimental production of neurofibrillary degeneration: I. Light microscopic observations. J. Neuropathol. Exp. Neurol. 24: 187, 1965.
DeBoni, U., Otvos, A., Scott, J.W. et al.: Neurofibrillary degeneration induced by systemic aluminum. Acta Neuropath. (Berl.) 35: 285, 1976.
Noordewier, B., Commissaris, R.L., Cordon, J. et al.: Effect of chronic oral aluminum on shuttlebox avoidance behavior in rats. (Abst.) Kidney Int. 14: 682, 1978.
Crapper, D.R. and Dalton, A.J.: Alterations in short-term retention, conditioned avoidance response acquisition and motivation following aluminum induced neurofibrillary degeneration. Physiol. Behav. 10: 925, 1973.
Crapper, D.R. and Dalton, A.J.: Aluminum-induced neurofibrillary degeneration, brain electrical activity and alteration in acquisition and retention. Physiol. Behav. 10: 935, 1973.
Alfrey, A.C., Mishell, J.M., Burks, J. et al.: Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans. Am. Soc. Artif. Int. Organs 18: 257, 1972.
Mahurkar, S.D., Smith, E.C., Mamdani, B.H. et al.: Dialysis dementia — the Chicago experience. J. Dialysis 2 (5&6): 447, 1978.
Burks, J.S., Alfrey, A.C., Huddlestone, J. et al.: A fatal encephalopathy in chronic hemodialysis patients. Lancet 1: 764, 1976.
Rosenbek, J.C, McNeil, M.R., Lemme, M.L. et al.: Speech and language findings in a chronic hemodialysis patient: à case report, J. Speech Hear. Dis. 40 (2): 245, 1975.
Nadel, A.M. and Wilson, W.P.: Dialysis encephalopathy: a possible seizure disorder. Neurology 26: 1130, 1976.
Martinez, W.C., Rapin, I. and Moore, C.L.: Neurologic complications of renal failure. In C.M. Edelmann, Jr. (ad.), Pediatric Kidney Disease, Boston, Little, Brown and Company, 1978, p. 417.
Pierides, A.M., Ward, M.K. and Kerr, D.N.S.: Haemodialysis encephalopathy: possible role of phosphate depletion. Lancet 1: 1234, 1976.
Raskin, N.H. and Fishman, R.A.: Neurologic disorders in renal failure. N. Engl. J. Med. 294 (4): 204, 1976.
Favero, M.S.: Epidemiologic investigation of dialysis encephalopathy. Proc. 11th Ann. Contract Conf. Artif. Kidney Chron. Uremia Prog. NIAMDD 11: 206, 1978.
Jacobs, C., Brunner, F.P., Chantier, C. et al.: Combined report on regular dialysis and transplantation in Europe, VII, 1976. Proc. Eur. Dial. Transpl. Assoc. 14: 3, 1977.
Buge, A., Poisson, M., Masson, S. et al.: Encephalopathie reversible des dialyses apres arret de l’apport d’aluminum. Nouv. Presse Med. 8 (34): 2729, 1979.
Guisado, R., Arieff, A.I. and Massry, S.G.: Changes in the electroencephalogram in acute uremia. Effects of parathyroid hormone and brain electrolytes. J. Clin. Invest. 55: 738, 1975.
Cogan, M.G., Covey, C.M., Arieff, A.I. et al.: Central nervous system manifestations of hyperparathyroidism. Am. J. Med. 65: 963, 1978.
Ball, J.H., Butkus, D.E. and Madison, D.S.: Effect of subtotal parathyroidectomy on dialysis dementia. Nephron 18: 151, 1977.
Baluarte, H.J., Gruskin, A.B., Hiner, L.B. et al.: Encephalopathy in children with chronic renal failure. Proc. Clin. Dial. Transpl. Forum 7: 95, 1977.
Polinsky, M.S., Prebis, J.W., Elzouki, A.Y. et al.: The dialysis encephalopathy syndrome in childhood: results of a survey to determine incidence and geographic distribution of cases. (Abst.) Chronic Renal Dis. Conf. NIAMDD, Bethesda, Md., 1980, p. 58.
Etheridge, W.B. and O’Neill, Jr., W.M. : The “dialysis encephalopathy syndrome” without dialysis. Clin. Nephrol. 10 (6): 250, 1978.
Parsons, V., Davies, C., Goode, C. et al.: Aluminum in bone from patients with renal failure. Br. Med. J. 2: 273, 1971.
Parkinson, I.S., Ward, M.K., Feest, T.G. et al.: Fracturing dialysis osteodystrophy and dialysis encephalopathy: an epidemiologic survey. Lancet 1: 406, 1979.
Alfrey, A.C., Hegg, A., Miller, N. et al.: Interrelationship between calcium and aluminum metabolism in dialyzed uremic patients. Mineral Electrolyte Metab. 2: 81, 1979.
Korsch, B.M., Fine, R.N., Grushkin, C.M. et al.: Experience with children and their families during extended hemodialysis and kidney transplantation. Pediatr. Clin. N. Am. 18: 625, 1971.
Elliott, H.L., Macdougall, A.L. and Fell, G.S.: Aluminum toxicity syndrome. Lancet 1: 1203, 1978.
Flendrig, J.A., Kruis, H. and Das, H.A.: Aluminum and dialysis dementia. Lancet 1: 1235, 1976.
Ward, M.K., Feest, T.G., Ellis, H.A. et al.: Ostomalacia dialysis osteodystrophy: evidence for a water-borne aetiologic agent, probably aluminum. Lancet 1: 841, 1978.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Plenum Press, New York
About this chapter
Cite this chapter
Polinksy, M.S., Gruskin, A.B., Baluarte, H.J., Prebis, J.W., Elzouki, A.Y. (1981). Aluminum in Chronic Renal Failure: A Pediatric Perspective. In: Strauss, J. (eds) Pediatric Nephrology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8804-3_27
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8804-3_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8806-7
Online ISBN: 978-1-4684-8804-3
eBook Packages: Springer Book Archive